References
- Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917
- Cancer Research. UK breast statistics; 2014. Available from: http://publications.cancerresearchuk.org/cancerstats/statsbreast/kfbreast.html [last accessed 7 May 2015]
- The Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778–86
- US Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2009;151:716
- Canadian Task Force on Preventive Health Care, Tonelli M, Connor Gorber S, Joffres M, et al. Recommendations on screening for breast cancer in average-risk women aged 40–74 years. CMAJ 2011;183:1991–2001
- Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6:CD001877
- Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: epidemiology and etiology. Cell Biochem Biophys 2015;72:333–8
- Parkin DM, Fernandez LMG. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12:S70–S80
- Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005;6:391–401
- Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012;156:635–48
- Forrest Sir P. Breast cancer screening: report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO; 1986:102
- Lind H, Svane G, Kemetli L, Törnberg SA. Breast cancer screening program in Stockholm County, Sweden: aspects of organization and quality assurance. Breast Care 2010;5:353–7
- Cases C, Di Palma M, Drahi E, et al. Concertation citoyenne et scientifique. Rapport du comité d’orientation. 2016. Available from: http://www.concertation-depistage.fr [last accessed 15 May 2017]
- Screening and Immunisations Team, Health and Social Care Information Centre. Breast Screening Programme, England, Statistics for 2014–15. February 24, 2016. Available from: http://content.digital.nhs.uk/catalogue/PUB20018/bres-scre-prog-eng-2014-15-rep.pdf
- NHS Breast Cancer Screening Programme; How much does the programme cost? Available from: http://webarchive.nationalarchives.gov.uk/20150506150512/http://www.cancerscreening.nhs.uk/breastscreen/cost.html [last accessed 20 Jan 2017]
- Department of Health. Public health functions to be exercised by NHS England. Service Specification No.24 Breast Screening Programme. 2013. Available from: www.nationalarchives.gov.uk/doc/open-government-licence/[last accessed 20 Jan 2017]
- NHS Breast Screening Programme. NHS breast screening statistics poster. Available from: http://webarchive.nationalarchives.gov.uk/20150506150512/http://www.cancerscreening.nhs.uk/breastscreen/publications/breast-screening-statistics-poster.pdf [last accessed 20 Jan 2017]
- Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer NICE. 2013. Available from: https://www.nice.org.uk/guidance/cg164/ifp/chapter/how-breast-cancer-risk-is-described [last accessed 20 Jan 2017]
- Public Health England. Protocols for the surveillance of women at higher risk of developing breast cancer, Version 4. NHSBSP Publication number 74, June 2013. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/440208/nhsbsp74.pdf
- Jenkins J, Sellars SJ, Wheaton M, Guidelines on organising the surveillance of women at higher risk of developing breast cancer in an NHS Breast Screening Programme. NHSBSP publication number 73. March 2013. Available from: http://webarchive.nationalarchives.gov.uk/20150506150512/http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp73.pdf
- Njor S, Nyström L, Moss S, et al. Breast Cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen 2012;19:33–41
- Duffy SW, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013;15:R41
- De Gelder R, Heijnsdijk EAM, Van Ravesteyn NT, Fracheboud J, Draisma G, De Koning HJ. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 2011;33:111–21
- Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502–10
- Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026–34
- Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005;14:917–38
- Seigneurin A, Exbrayat C, Labarère J, Delafosse P, Poncet F, Colonna M. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Breast Cancer Res Treat 2011;127:221–8
- Alamo-Junquera D, Murta-Nascimento C, Macia F, et al. Effect of false-positive results on reattendance at breast cancer screening programmes in Spain. Eur J Public Health 2012;22:404–8
- Maxwell AJ, Beattie C, Lavelle J, et al. The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study. J Med Screen 2013;20:91–8
- Berrington de González A. Estimates of the potential risk of radiation-related cancer from screening in the UK. J Med Screen 2011;18:163–4
- Young KC, Faulkner K, Wall B, Muirhead C. Review of Radiation Risk in Breast Screening. NHSBSP Report 54. Sheffield: NHS Cancer Screening Programme, 2003
- Moser K, Sellars S, Wheaton M, et al. Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen 2011;18:96–102
- Gilbert FJ, Tucker L, Gillan MG, et al. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme: a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone. Health Technol Assess 2015;19:1–136
- Lei J, Yang P, Zhang L, Wang Y, Yang K. Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol 2014;24:595–602
- Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013;267:47–56
- Fallenberg EM, Schmitzberger FF, Amer H, et al. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation. Eur Radiol 2017;27:2752–64
- Jochelson MS, Dershaw DD, Sung JS, et al. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013;266:743–51
- Chou CP, Lewin JM, Chiang CL, et al. Clinical evaluation of contrast-enhanced digital mammography and contrast enhanced tomosynthesis – comparison to contrast-enhanced breast MRI. Eur J Radiol 2015;84:2501–8